The Global Small Animal Imaging In Vivo Market Size is valued at 2.36 billion in 2022 and is predicted to reach 5.11 billion by the year 2031 at a 9.16% CAGR during the forecast period for 2023-2031.
As technology continues to advance, multimodal instruments are being developed and used at a rapid rate in both preclinical and clinical settings. In addition, SPECT/CT scanners are increasingly frequently utilized for regular analysis. Dual-modality or hybrid PET/CT scanners are favored systems for clinical nuclear medicine. These multimodal devices benefit from combining the functional strength of one technology, such SPECT and PET, with the high-resolution anatomical imaging provided by CT or MRI.
Recent improvements in preclinical in-vivo modalities include PET/CT, PET/MRI, and SPECT/CT. The development of the market is greatly influenced by technological improvements. The M2 3D MR-based histology system, for example, was introduced by Aspect Imaging for in-vivo and ex-vivo toxicological imaging.
For high-throughput in-vivo and ex-vivo imaging of preclinical subjects, the M2 3D MR-based histology system is a portable, multimodal, and high-resolution MRI device. High-resolution 3D images of internal and anatomical morphology, as well as quantitative data on illness development and regression, are just a few of the many advantages of MRI that the M2 offers.
Recent Developments:
- In November 2021, The establishment of an Advanced In Vivo Imaging Facility at the Indian Institute of Science Education and Research (IISER) Pune has been announced by PerkinElmer India, a leading company dedicated to innovating for a healthier world.
Competitive Landscape:
Some of the Small Animal Imaging In Vivo market players are:
- Aspect Imaging Ltd.
- Bruker Corporation
- CMR Naviscan (US)
- FUJIFILM Holdings Corporation
- General Electric (US)
- Hitachi Ltd. (Japan)
- Koninklijke Philips N.V. (Netherlands)
- Life Technologies Corporation
- Mediso Medical Imaging Systems
- Miltenyi Biotech GmbH
- PerkinElmer, Inc.
- Promega Corporation
- SCANCO Medical AG (Switzerland)
- Siemens Healthcare GmbH (Germany)
- Thermo Fisher Scientific
Market Segmentation:
The Small Animal Imaging In Vivo market is categorized on the basis of technology and application. Based on technology, the market is segregated as Micro-MRI, Optical, Nuclear imaging, Micro-ultrasound. The application segment includes Cancer cell detection, Bio-distribution, Monitoring Therapy Response, Longitudinal Studies, Epigenetic Studies.
Based On Technology, The Optical Segment Is Accounted As A Major Contributor In The Small Animal Imaging In Vivo Market
The optical segment category is expected to hold a major share in the global Small Animal Imaging In Vivo market in 2021. Since that operates quickly and simply and is more cost-effective than other modalities, optical imaging accounted for the highest revenue category. Due to features like precise and targeted operations that aid in producing better outcomes in preclinical research, micro-MRI technology is anticipated to see the greatest CAGR during the forecast period.
Bio-Distribution Segment Witnessed Growth At A Rapid Rate
The two biggest application sectors are bio-distribution and tracking the treatment's effectiveness. The largest segment, bio-distribution, is anticipated to continue on its current trajectory during the projected period. In order to determine medication efficacy, optimize drug formulations, and identify acceptable profiles, drug-target engagement assessment of novel compounds or preclinical bio-distribution is essential. Non-invasive near-infrared (NIR) fluorescence imaging allows for real-time observation and detection of a new drug's bio-distribution across the entire body.
The North America Small Animal Imaging In Vivo Market Maintains A Significant Revenue Share In The Region
The region that brought in the most money was North America. Innovative modality innovations brought on by technological advancements are to blame for the market development in the area. Several preclinical studies conducted throughout the region are anticipated to aid the market's growth during the forecast period significantly. The presence of numerous producers of diagnostic devices, clinical research organizations, and pharmaceutical companies is expected to make Europe the second-largest market throughout the projection period. Due to the shifting of clinical research efforts from developed to developing countries, the Asia Pacific region is predicted to increase at the quickest rate during the projection period.
Small Animal Imaging In Vivo Market Report Scope:
|
Report Attribute |
Specifications |
|
Market size value in 2022 |
USD 2.36 Bn |
|
Revenue forecast in 2031 |
USD 5.11 Bn |
|
Growth rate CAGR |
CAGR of 9.16 % from 2023 to 2031 |
|
Quantitative units |
Representation of revenue in US$ Billion, and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report coverage |
The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends |
|
Segments covered |
Technology and Application |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
|
Competitive Landscape |
Bruker (US), General Electric (US), Koninklijke Philips N.V. (Netherlands), Hitachi Ltd. (Japan), Siemens Healthcare GmbH (Germany), FUJIFILM Corporation (Japan), Bruker (US), PerkinElmer Inc (US), Miltenyi Biotec (Germany), CMR Naviscan (US), SCANCO Medical AG (Switzerland), Aspect Imaging Ltd (Israel). |
|
Customization scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and available payment methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
